SBC Medical Group Holdings Incorporated
IndustrialsNASDAQ:SBC · NASDAQ Global Market
-$0.12 today
Vol 0.08M · Avg 0.12M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
20.5%
avg 19.5%
ROIC
12.6%
avg 14.7%
ROA
13.4%
avg 12.2%
Analysis
ROE is currently the strongest return metric at 20.5% versus its period average of 19.5%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Yoshiyuki Aikawa | Chairman & Chief Executive Officer | $12.00M | — | 55 | $78.84M | 76.66% |
Miki Yamazaki | Chief Strategy Officer | $463,696.00 | — | 40 | $0.00 | <0.01% |
Yuya Yoshida | Chief Operating Officer, Chief Financial Officer & Director | $416,072.00 | — | 46 | $0.00 | <0.01% |
Ryoji Murata | Principal Accounting Officer | $136,990.00 | — | 54 | $0.00 | <0.01% |
Yoshimune Tanaka | Property Acquisition Director | $103,740.00 | — | — | — | — |
Hikaru Fukui | Head of IR & CHRO of SBC Medical Group Co., Ltd. (Japan) | — | — | — | — | — |
Hiroyuki Miya | Chief Operating Officer of SBC Medical Group Co., Ltd. (Japan) | — | — | — | — | — |
Kazuki Ichimori | Chief Corporate Development Officer | — | — | — | — | — |
Shengfu Hsiao | Chief Technology Officer | — | — | — | — | — |
Shinya Inoue | Chief Marketing Officer | — | — | — | — | — |
Akiko Wakiyama | Chief Public Relations Officer | — | — | — | — | — |
Taiki Sakaguchi | CHRO, Chief Planning Officer & Corporate Secretary | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
3
$20.15M
Net Sentiment
$20.15M
Net selling
Most Active
Aikawa Yoshiyuki
3 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 3 sells worth $20.15M over the last 12 months. That adds up to net selling of $20.15M. Aikawa Yoshiyuki was the most active insider with 3 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +99.8% | +0.0% (3yr)1 analysts |
| Revenue | N/A | N/A | -0.1% | +4.4% (3yr)2 analysts |
| Net Income | N/A | N/A | +100.6% | +0.2% (3yr)2 analysts |
| EBIT | N/A | N/A | +49.7% | -0.5% (3yr)2 analysts |
Analysis
Recent growth has been strongest in Net Income at +100.6% over three years. Forward estimates point to Revenue at +4.4% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Spire Global, Inc.
NYSE:SPIR
$593.14M
Concrete Pumping Holdings, Inc.
NASDAQ:BBCP
$560.37M
Pangaea Logistics Solutions, Ltd.
NASDAQ:PANL
$502.39M
Luxfer Holdings PLC
NYSE:LXFR
$488.28M
The Manitowoc Company, Inc.
NYSE:MTW
$447.43M
Wabash National Corporation
NYSE:WNC
$395.76M
ACCO Brands Corporation
NYSE:ACCO
$372.72M
KNOT Offshore Partners LP
NYSE:KNOP
$363.53M
flyExclusive, Inc.
AMEX:FLYX
$162.18M
Rich Sparkle Holdings Limited Ordinary Shares
NASDAQ:ANPA
$67.63M
Who manages SBC?
SBC Medical Group Holdings Incorporated (SBC) lists 12 active executives. The top listed executive is Yoshiyuki Aikawa, Chairman & Chief Executive Officer.
Are SBC insiders buying or selling?
Recent insider activity shows net selling of $132.75M.
Explore More
Continue the stock analysis
Jump to another research area for this company.